Parkinson’s disease is a progressive condition that can affect movement, thinking, and emotions. It’s associated with low levels of dopamine, a chemical in the brain.
Learn the role of dopamine in the development of Parkinson’s disease, as well as the risk factors, according to Jason Krellman, PhD, Neuropsychologist at Columbia University Irving Medical Center.
Jason Krellman, PhD, ABPP-CN, is a Neuropsychologist at Columbia University Irving Medical Center.
References
American Association of Neurological Surgeons. (n.d.). Parkinson’s disease.
Li, S., et al. (2017). Milestones of Parkinson’s disease research: 200 years of history and beyond. Neuroscience Bulletin.
MedlinePlus. (2019). Parkinson’s disease.
MedlinePlus. (2022). Substantia nigra and Parkinson disease.
National Institute on Aging. (2022). Parkinson’s disease: Causes, symptoms, and treatments.
Sonne, J., et al. (2022). Neuroanatomy, substantia nigra. StatPearls.
Zafar, S., et al. (2022). Parkinson disease. StatPearls.
Why trust our experts?
